tiprankstipranks
Viemed Healthcare US (VMD)
NASDAQ:VMD
Want to see VMD full AI Analyst Report?

Viemed Healthcare (VMD) Price & Analysis

180 Followers

VMD Stock Chart & Stats

$6.88
$0.08(0.94%)
At close: 4:00 PM EST
$6.88
$0.08(0.94%)

Bulls Say, Bears Say

Bulls Say
High Gross & EBITDA MarginsViemed's consistently high gross margins and steady EBITDA margins reflect durable unit economics from rental and resupply businesses. High service-driven gross margins provide a cushion vs. reimbursement pressure, support reinvestment in clinical capabilities, and sustain profitability over the medium term.
Diversified, Recurring Revenue MixGrowth in PAP patients and rapidly expanding equipment & supply sales shift revenue away from ventilator concentration toward recurring resupply and sales. This diversification improves revenue predictability, reduces single-product dependency, and enhances capital efficiency across the home-care platform.
Conservative Balance Sheet & LiquidityVery low leverage and available credit capacity give Viemed flexibility for working capital, acquisitions, or weathering reimbursement cycles. Debt reduction and liquidity provide durable financial optionality, lowering default risk and enabling capital allocation to growth or shareholder returns over the medium term.
Bears Say
Ventilator Census & Policy Compliance RiskNew NCD compliance criteria have raised ventilator patient turnover and temporary loss risk, reducing the predictability of a historically large rental revenue stream. Given ventilators remain a material portion of revenue, sustained census pressure could depress recurring revenue and utilization over several quarters.
Volatile Free Cash Flow ConversionOperating cash flow is strong, but free cash flow has been inconsistent due to working-capital and investment timing. Irregular FCF conversion constrains predictable funding for capex, acquisitions, debt paydown, or buybacks, making capital allocation and balance-sheet strengthening less certain in the medium term.
Rising SG&A & Potential Equity DilutionAbsolute SG&A growth from integration and headcount raises the ongoing fixed-cost base, pressuring bottom-line conversion. An expanded long‑term incentive reserve supports retention but increases potential share-based dilution, which can dilute EPS and constrain per-share returns if issuance accelerates.

Viemed Healthcare News

VMD FAQ

What was Viemed Healthcare US’s price range in the past 12 months?
Viemed Healthcare US lowest stock price was $5.93 and its highest was $10.68 in the past 12 months.
    What is Viemed Healthcare US’s market cap?
    Viemed Healthcare US’s market cap is $400.24M.
      When is Viemed Healthcare US’s upcoming earnings report date?
      Viemed Healthcare US’s upcoming earnings report date is Aug 12, 2026 which is in 55 days.
        How were Viemed Healthcare US’s earnings last quarter?
        Viemed Healthcare US released its earnings results on May 05, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by -$0.03.
          Is Viemed Healthcare US overvalued?
          According to Wall Street analysts Viemed Healthcare US’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Viemed Healthcare US pay dividends?
            Viemed Healthcare US does not currently pay dividends.
            What is Viemed Healthcare US’s EPS estimate?
            Viemed Healthcare US’s EPS estimate is 0.12.
              How many shares outstanding does Viemed Healthcare US have?
              Viemed Healthcare US has 38,336,803 shares outstanding.
                What happened to Viemed Healthcare US’s price movement after its last earnings report?
                Viemed Healthcare US reported an EPS of $0.06 in its last earnings report, missing expectations of $0.09. Following the earnings report the stock price went down -12.216%.
                  Which hedge fund is a major shareholder of Viemed Healthcare US?
                  Currently, no hedge funds are holding shares in VMD
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Viemed Healthcare US

                    Viemed Healthcare, Inc., through its operating subsidiaries, delivers essential in-home durable medical equipment (DME) and specialized post-acute respiratory healthcare services to patients throughout the United States. The company's core focus is on respiratory disease management, particularly for chronic obstructive pulmonary disease (COPD). This encompasses a range of solutions such as non-invasive ventilation (NIV), percussion vests, and various other therapeutic interventions. They supply both invasive and non-invasive ventilation equipment and related accessories specifically for individuals with COPD. Viemed facilitates access to necessary equipment through leasing and sales. Their offerings include non-invasive and invasive ventilators, positive airway pressure (PAP) machines, percussion vests, oxygen concentrator units, and other vital small respiratory devices. In addition to DME, they also provide patient medical services. Beyond respiratory care, Viemed extends its services to include neuromuscular care and oxygen therapy. They are also a key provider in sleep apnea management, supplying equipment like PAP, automatic continuous positive airway pressure (APAP), and bi-level positive airway pressure (BiPAP) machines. Furthermore, the company conducts convenient in-home sleep apnea testing. Established in 2006, Viemed Healthcare, Inc. maintains its headquarters in Lafayette, Louisiana.

                    Viemed Healthcare (VMD) Earnings & Revenues

                    VMD Company Deck

                    VMD Earnings Call

                    Q1 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call presented strong operational and financial progress: revenue growth of 28% YoY, substantial free cash flow improvement, meaningful scaling in sleep (PAP up 57% YoY) and maternal health expansion, improved capital efficiency and a stronger, more diversified revenue mix. Near-term headwinds are largely related to NCD-driven compliance effects in ventilation (higher turnover and temporary pressure on net census), some seasonality, and comparability issues from a prior-year gain. Management reiterated positive guidance, tightened revenue guidance upward, and highlighted continued margin and cash-flow improvement, indicating confidence in execution.View all VMD earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Inogen
                    Senseonics Holdings
                    Tactile Systems Technology
                    Outset Medical
                    Bioventus

                    Ownership Overview

                    13.72%13.09%23.62%41.68%
                    13.72% Insiders
                    23.62% Other Institutional Investors
                    41.68% Public Companies and
                    Individual Investors
                    Popular Stocks